ROS1 GENE REARRANGEMENT

Clinical trials for ROS1 GENE REARRANGEMENT explained in plain language.

Never miss a new study

Get alerted when new ROS1 GENE REARRANGEMENT trials appear

Sign up with your email to follow new studies for ROS1 GENE REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug trial targets lung cancer in the brain

Disease control Recruiting now

This study is testing a drug called repotrectinib for people with a specific type of lung cancer (ROS1-positive NSCLC) that has spread to the brain. The main goal is to see if the drug is safe and can shrink or control the brain tumors. It will enroll about 20 participants who wi…

Matched conditions: ROS1 GENE REARRANGEMENT

Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control

Last updated Apr 01, 2026 21:25 UTC

ROS1 GENE REARRANGEMENT

Get alerted when new ROS1 GENE REARRANGEMENT trials appear

New drug trial targets lung cancer in the brain